^
Association details:
| Biomarker: | HER-2 R896G |
|---|---|
| Cancer: | Non Small Cell Lung Cancer |
| Drug: | Gilotrif (afatinib) (EGFR inhibitor, HER2 inhibitor, HER4 inhibitor) |
| Direction: | Sensitive |
Evidence:
Source:
Title:
Response to Afatinib in a Patient with Non-Small Cell Lung Cancer Harboring HER2 R896G Mutation: A Case Report
Excerpt:
This is the first case report describing a NSCLC patient harboring a rare HER2 R896G mutation who responds to afatinib.
DOI:
10.2147/OTT.S228726
